Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

238
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
238

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinicoepidemiological profile of snake bite cases in a tertiary care center from Coastal Karnataka.

La Clinica terapeutica·2026
Same author

A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF.

Hepatology international·2026
Same author

A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF.

Hepatology (Baltimore, Md.)·2026
Same author

A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF.

Annals of hepatology·2026
Same author

A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF.

Journal of hepatology·2026
Same author

Genome-Wide Association Study to Identify Novel Genetic Variants Associated With Primary Budd-Chiari Syndrome.

Journal of clinical and experimental hepatology·2026

Related Experiment Video

Updated: Oct 20, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.4K

Primary Versus Secondary NAFLD: Perspective on Advanced Fibrosis.

Divya Shetty1, Anjali Amarapurkar2, Akash Shukla3

  • 1Department of Pathology, Dr. DY Patil Medical College, Hospital and Research Centre, Nerul, Navi, Mumbai, India.

Journal of Clinical and Experimental Hepatology
|September 13, 2021
PubMed
Summary

Primary nonalcoholic fatty liver disease (NAFLD) shows more severe histopathological features, including advanced fibrosis, compared to secondary NAFLD. This suggests primary NAFLD may represent a more aggressive liver disease.

Keywords:
ALT, Alanine aminotransferaseAST, Aspartate aminotransferaseHBV, Hepatitis B virusHCC, Hepatocellular carcinomaHIV, Human immunodeficiency virusMDB, Mallory hyaline bodiesMTX, MethotrexateNAFLD, Nonalcoholic fatty liver diseaseNAS, NAFLD activity scoreNASH, Nonalcoholic steatohepatitisadvanced fibrosisinflammationnon-alcoholic fatty liver diseaseprimary NAFLDsecondary NAFLD

More Related Videos

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

1.5K
3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis
06:46

3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis

Published on: February 25, 2022

2.0K

Related Experiment Videos

Last Updated: Oct 20, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.4K
Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
06:09

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI

Published on: July 21, 2023

1.5K
3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis
06:46

3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis

Published on: February 25, 2022

2.0K

Area of Science:

  • Hepatology
  • Gastroenterology
  • Pathology

Background:

  • Macrovesicular steatosis is a common liver biopsy finding, defining nonalcoholic fatty liver disease (NAFLD) when alcohol use is excluded.
  • NAFLD is categorized into primary and secondary types, with limited understanding of their distinct histopathological characteristics and fibrosis progression.

Purpose of the Study:

  • To investigate the histopathological differences between primary and secondary NAFLD.
  • To compare the prevalence of advanced fibrosis in primary versus secondary NAFLD.

Main Methods:

  • Retrospective analysis of 90 liver biopsies with ≥5% macrovesicular steatosis over three years.
  • Evaluation of histopathological features including steatosis, inflammation, ballooning degeneration, Mallory Denk bodies, glycogenated nuclei, and fibrosis stage.
  • Statistical comparison of demographic, clinical, and histopathological data between primary and secondary NAFLD groups.

Main Results:

  • Primary NAFLD (46.7%) and secondary NAFLD (53.3%) showed significant differences in ballooning degeneration, Mallory Denk bodies, glycogenated nuclei, and fibrosis stage (p < 0.05).
  • The overall prevalence of advanced fibrosis was 24.4%.
  • No significant differences were observed in AST/ALT ratio, steatosis, or inflammation grade between the two groups.

Conclusions:

  • Primary NAFLD is characterized by more severe histopathological findings, including a higher prevalence of ballooning degeneration, Mallory Denk bodies, glycogenated nuclei, and advanced fibrosis.
  • These findings suggest that primary NAFLD represents a more aggressive form of liver disease compared to secondary NAFLD.